📈 Stocks
📊 Neutral
🌍 United States
Quest Diagnostics CEO J.E. Davis Sells 10,000 Shares for $2.4 Million
CEO J.E. Davis sold 10,000 shares of Quest Diagnostics at $242.72 per share, a move facilitated by a pre-established 10b5-1 trading plan that maintains his significant $28.9 million equity position in the firm.
Impact
10/10
💡 Key Takeaways
- CEO J.E. Davis sold 10,000 shares at $242.72, totaling $2.4 million in proceeds.
- The transaction was conducted via a Rule 10b5-1 plan, signaling routine financial management rather than a shift in company outlook.
- Quest Diagnostics maintains a $26.5 billion market cap with 10% year-over-year revenue growth.
📋 Executive Summary
Quest Diagnostics CEO J.E. Davis offloaded 10,000 shares of company stock on September 1, 2026, in a transaction valued at $2.4 million. The sale was executed under a pre-arranged Rule 10b5-1 trading plan, leaving the executive with a remaining direct stake of 122,423 shares valued at approximately $28.9 million.
📊 Sentiment Analysis
Sentiment
📊 Neutral
Impact Score
10/10
Region
🌍 United States
Asset Class
📈 Stocks
❓ Frequently Asked Questions
The sale was executed under a Rule 10b5-1 trading plan, which allows insiders to schedule trades in advance for personal liquidity needs, independent of current company fundamentals.
📰 Source
📅 Originally published:
⚠️ Disclaimer: This content is for training purposes only and should not be considered financial advice. Always conduct your own research before making investment decisions.